Therapy for newly diagnosed patients with mantle cell lymphoma - European Medical Journal

Therapy for newly diagnosed patients with mantle cell lymphoma

Oncology
At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses new data that support earlier treatment of patients with mantle cell lymphoma (MCL), including the results of an investigation of a bortezomib-based regimen as frontline therapy for patients with newly diagnosed MCL.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now